NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, moderates the discussion with Lori K. Handy, MD, MSCE, Attending Physician at Children’s Hospital of Philadelphia and Associate Professor of Clinical Pediatrics at Perelman School of Medicine at the University of Pennsylvania, and Joshua T.B. Williams, MD, Pediatrician at Denver Health and Associate Professor of Pediatrics at the University of Colorado Anschutz School of Medicine.

At the conclusion of the activity, participants will be able to:

• Discuss current evidence-based vaccine recommendations in the US for children
• Discuss burden of vaccine-preventable diseases among children
• Implement effective communication strategies to improve vaccine confidence

There is no fee to participate in this activity, but pre-registration is required:

The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

NFID designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, moderated the discussion with NFID Vice President Kevin A. Ault, MD, Chair and Professor of Obstetrics and Gynecology at Western Michigan University Homer Stryker MD School of Medicine, and Camille N. Kotton, MD, Clinical Director of Transplant and Immunocompromised Host Infectious Diseases at Massachusetts General Hospital.  

At the conclusion of the activity, participants will be able to:

• Discuss current evidence-based recommendations for COVID-19, influenza, RSV, and pneumococcal vaccines among pregnant women and immunocompromised individuals 
• Discuss disparities in respiratory immunization rates among pregnant women and immunocompromised individuals
• Identify practical strategies to increase respiratory immunization rates among pregnant women and immunocompromised individuals

There is no fee to participate in this activity, but pre-registration is required:

The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

NFID designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, moderates the discussion with NFID Director Matthew M. Zahn, MD, Pediatric Infectious Disease Physician at Rady Children’s Health, Melody Butler, MPH, BSN, RN, CIC, Founding Executive Director and President of Nurses Who Vaccinate and Director of Infection Prevention and Control at Stony Brook Southampton Hospital, and Brigid K. Groves, PharmD, MS, Vice President of Professional Affairs at the American Pharmacists Association (APhA).  

At the conclusion of the activity, participants will be able to:

• Discuss current evidence-based recommendations for COVID-19, influenza (flu), respiratory syncytial virus (RSV), and pneumococcal disease immunization in the US 
• Describe the burden of COVID-19, flu, RSV, and pneumococcal disease in the US
• Implement communication strategies to help increase respiratory disease immunization rates in the US

There is no fee to participate in this activity, but pre-registration is required:

The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

NFID designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, moderates the discussion with Erin O’Malley, Executive Director, Coalition for Trust in Health & Science, and NFID Director Jean-Venable (Kelly) R. Goode, PharmD, Professor and Director of the Community-Based Pharmacy Residency Program at Virginia Commonwealth University. 

At the conclusion of the activity, participants will be able to:

• Discuss the burden of vaccine-preventable diseases in the US
• Describe strategies to identify mis- and disinformation
• Implement practical communication strategies to help build trust with patients and caregivers and increase vaccine confidence

There is no fee to participate in this activity, but pre-registration is required:

The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

NFID designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This activity is supported by an unrestricted educational grant from Merck & Co., Inc. NFID policies restrict funders from controlling program content. 

NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, moderates the discussion with Lin H. Chen, MD, Associate Professor of Medicine at Harvard Medical School and Travel Medicine Consultant at Mount Auburn Hospital Travel Medicine Center, and NFID President Jeffery A. Goad, PharmD, MPH, Professor of Pharmacy Practice at Chapman University School of Pharmacy.   

At the conclusion of the activity, participants will be able to:

• Discuss vaccine recommendations for international travelers
  
• Identify successful strategies for implementation of travel vaccine recommendations

There is no fee to participate in this activity, but pre-registration is required:

The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

NFID designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This activity is supported by an unrestricted educational grant from Merck & Co., Inc. NFID policies restrict funders from controlling program content. 

NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, moderates the discussion with Kristina A. Bryant, MD, Professor of Pediatric Infectious Diseases at the University of Louisville School of Medicine, and Michele F. Slafkosky, Executive Director of Families Fighting Flu.  

At the conclusion of the activity, participants will be able to:

• Discuss respiratory immunization rates during the 2024-2025 season in the US
• Describe the burden of respiratory diseases in the US
• Implement strategies to increase respiratory vaccination rates in the US

There is no fee to participate in this activity, but pre-registration is required:

The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

NFID designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*Note: There has been inconsistent use of a middle initial for Kristina Bryant, MD. The updated middle initial is A (not K). We apologize for any confusion.

NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, moderates the discussion with Adjoa Kyerematen, MS, Vice President of Public Affairs and Communications, National Minority Quality Forum, Reed V. Tuckson, MD, Chair of Board of the Coalition for Trust in Health & Science, and Julissa Soto, MPH, Principal, Julissa Soto Consulting. 

At the conclusion of the activity, participants will be able to:

• Identify issues, barriers, and challenges that impact vaccination rates in the US 
• Evaluate strategies to reduce barriers to equitable vaccine access and uptake in the US

There is no fee to participate in this activity, but pre-registration is required:

The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

NFID designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This webinar is supported by an unrestricted educational grant from Merck & Co., Inc. NFID policies restrict funders from controlling program content. 

NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, moderates the discussion with NFID Director Jean-Venable (Kelly) R. Goode, PharmD, Professor and Director of the Community-Based Pharmacy Residency Program at Virginia Commonwealth University and Litjen (L.J) Tan, MS, PhD, Chief Policy and Partnerships Officer, Immunize.org

There is no fee to participate in this activity, but pre-registration is required.

At the conclusion of the activity, participants will be able to:

• Discuss current recommendations for adult vaccination in the US
• Discuss adult immunization coverage and barriers in the US
• Implement strategies to increase adult immunization rates in the US

There is no fee to participate in this activity, but pre-registration is required: https://nfid.app.neoncrm.com/np/clients/nfid/eventRegistration.jsp?event=616&

The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

NFID designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, moderates the discussion with NFID Vice President Kevin A. Ault, MD, Chair of Obstetrics and Gynecology at Western Michigan University Homer Stryker MD School of Medicine, and NFID Director Flor M. Muñoz, MD, MSc, Associate Professor of Pediatrics, Infectious Diseases at Baylor College of Medicine.

At the conclusion of the activity, participants will be able to:

• Describe the importance of immunization in protecting pregnant women and infants 
• Discuss disparities in immunization rates among pregnant women in the US
• Identify strategies for improving vaccination coverage among pregnant women in the US

There is no fee to participate in this activity, but pre-registration is required: https://nfid.app.neoncrm.com/eventReg.jsp?event=611&

The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

NFID designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This webinar is supported by an unrestricted educational grant from Merck & Co., Inc. NFID policies restrict funders from controlling program content.